Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurin

Dowey, R., Cole, J., Roger Thompson, A.A. et al. (11 more authors) (2022) Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurin. ERJ Open Research, 8 (2). 00596-2021. ISSN 2312-0541

Abstract

Metadata

Authors/Creators:
  • Dowey, R.
  • Cole, J.
  • Roger Thompson, A.A.
  • Hull, R.C.
  • Huang, C.
  • Whatmore, J.
  • Iqbal, A.
  • Bradley, K.L.
  • McKenzie, J.
  • Lawrie, A. ORCID logo https://orcid.org/0000-0003-4192-9505
  • Condliffe, A.M.
  • Kiss-Toth, E.
  • Sabroe, I.
  • Prince, L.R.
Copyright, Publisher and Additional Information: © The Authors 2022. This version is distributed under the terms of the Creative Commons Attribution Licence 4.0. (http://creativecommons.org/licenses/by/4.0)
Keywords: Neutrophil; COVID-19; NETosis; Ruboxistaurin
Dates:
  • Accepted: 13 January 2022
  • Published (online): 4 April 2022
  • Published: 1 April 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
BRITISH HEART FOUNDATIONFS/18/13/33281
MEDICAL RESEARCH COUNCILMR/V028448/1
Depositing User: Symplectic Sheffield
Date Deposited: 03 Mar 2022 14:13
Last Modified: 05 Apr 2022 11:39
Status: Published
Publisher: European Respiratory Society
Refereed: Yes
Identification Number: https://doi.org/10.1183/23120541.00596-2021

Download

Share / Export

Statistics